Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Annamaria Scattolin"'
Autor:
Francesco Merli, Carlo Visco, Annarita Conconi, Daniele Vallisa, Elettra Ortu La Barbera, Sara Galimberti, Roberto Mina, Marianna Sassone, Anna Guidetti, Adriano Venditti, Alessandro Corso, Francesco Marchesi, Pellegrino Musto, Agostino Tafuri, Valentina Bonuomo, Filippo Gherlinzoni, Francesco Lanza, Monia Marchetti, Safaa M. Ramadan, Marco Salvini, Massimo Massaia, Elisa Coviello, Alessandro Busca, Luigi Petrucci, Daniele Armiento, Mauro Turrini, Alessandra Romano, Chiara Cattaneo, Francesco Passamonti, Matteo G. Della Porta, Anna Candoni, Luigi Rigacci, Luca Arcaini, Livio Trentin, Valeria Cardinali, Maria Chiara Tisi, Carmine Selleri, Carlo Gambacorti-Passerini, Andrés J.M. Ferreri, Patrizia Tosi, Riccardo Bruna, Mauro Krampera, Antonio Cuneo, Nicola Stefano Fracchiolla, Daniela Cilloni, Lorenza Bertù, Paolo Corradini, Annamaria Scattolin, Roberto Cairoli, Giuseppe Visani, Domenico Penna, Marco Ladetto, Antonello Pinto, Michele Cavo, Monica Bocchia, Sofia Pilerci, Luigi Marcheselli
Publikováno v:
Blood Advances
Lymphoma represents a heterogeneous hematological malignancy (HM), which is characterized by severe immunosuppression. Patients diagnosed of coronavirus disease 2019 (COVID-19) during the course of HM have been described to have poor outcome, with on
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c511abaff8f6767b1c8847f0db05744
http://hdl.handle.net/11568/1132840
http://hdl.handle.net/11568/1132840
Autor:
Michele Merli, Isacco Ferrarini, Francesco Merli, Alessandro Busca, Roberto Mina, Brunangelo Falini, Riccardo Bruna, Roberto Cairoli, Monia Marchetti, Alessandra Romano, Michele Cavo, Luca Arcaini, Livio Trentin, Chiara Cattaneo, Enrico Derenzini, Nicola Stefano Fracchiolla, Francesco Marchesi, Annamaria Scattolin, Atto Billio, Monica Bocchia, Massimo Massaia, Carlo Gambacorti‐Passerini, Francesca Romana Mauro, Massimo Gentile, Sara Mohamed, Matteo Giovanni Della Porta, Elisa Coviello, Daniela Cilloni, Giuseppe Visani, Augusto Bramante Federici, Maria Chiara Tisi, Laura Cudillo, Sara Galimberti, Filippo Gherlinzoni, Livio Pagano, Anna Guidetti, Lorenza Bertù, Paolo Corradini, Francesco Passamonti, Carlo Visco
COVID-19, the disease caused by SARS-CoV-2, is still afflicting thousands of people across the globe. Few studies on COVID-19 in chronic lymphocytic leukemia (CLL) are available. Here, we analyzed data from the CLL cohort of the Italian Hematology Al
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e896a46defa346fed22a387f3cd575e
https://hdl.handle.net/20.500.11769/542050
https://hdl.handle.net/20.500.11769/542050
Autor:
Renato Bassan, Chiara Pavoni, Pamela Zanghì, Elisabetta Todisco, Nicola Stefano Fracchiolla, Anna Michelato, Leonardo Campiotti, Federico Lussana, Roberta Cavagna, Annamaria Scattolin, Giacomo Gianfaldoni, Chiara Caprioli, Erika Borlenghi, Fabio Ciceri, Ernesta Audisio, Alessandro Rambaldi, Lorella De Paoli, Tamara Intermesoli, Elisabetta Terruzzi, Orietta Spinelli, Ksenija Buklijas, Lara Elidi, Silvia Salmoiraghi, Paola Stefanoni, Paolo Corradini, Daniele Mattei, Irene Cavattoni, Monica Tajana, Elena Oldani
Publikováno v:
Cancers, Vol 12, Iss 2242, p 2242 (2020)
Cancers
Volume 12
Issue 8
Cancers
Volume 12
Issue 8
By way of a Next-Generation Sequencing NGS high throughput approach, we defined the mutational profile in a cohort of 221 normal karyotype acute myeloid leukemia (NK-AML) enrolled into a prospective randomized clinical trial, designed to evaluate an
Autor:
Piera Viero, Francesca Gianni, Rosaria Sancetta, Francesca Carobolante, Paola Stefanoni, Renato Bassan, Tamara Intermesoli, Alessandro Rambaldi, Elena Maino, Manuela Tosi, Annamaria Scattolin, Orietta Spinelli
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 17:S2-S9
The study of minimal residual disease (MRD) in adult patients with acute lymphoblastic leukemia (ALL) allows a greater refinement of the individual risk classification and is the best support for risk-specific therapy with or without allogeneic hemat
Autor:
Massimo Dozzo, Piera Viero, Francesca Carobolante, Annamaria Scattolin, Elena Maino, Renato Bassan, Pietro Maria Donisi, Rosaria Sancetta
Publikováno v:
Adolescent Health, Medicine and Therapeutics
About one-half of all Burkitt lymphoma (BL) patients are younger than 40 years, and one-third belong to the adolescent and young adult (AYA) subset, defined by an age between 15 and 25–40 years, based on selection criteria used in different reports
Autor:
Chiara Caprioli, Dario Ferrero, Monica Tajana, Irene Cavattoni, Leonardo Campiotti, Agostino Cortelezzi, Paolo Corradini, Roberta Cavagna, Annamaria Scattolin, Alberto Bosi, Ksenija Buklijas, Elisabetta Terruzzi, Ernesta Audisio, Silvia Salmoiraghi, Filippo Marmont, Orietta Spinelli, Massimo Bernardi, L De Paoli, Federico Lussana, Federica Delaini, Lara Elidi, Chiara Pavoni, Pamela Zanghì, Renato Bassan, Giuseppe Rossi, Daniele Mattei, Erika Borlenghi, Elisabetta Todisco, Alessandro Rambaldi, Tamara Intermesoli, Elena Oldani, Anna Michelato, Brunangelo Falini, Giacomo Gianfaldoni, Fabio Ciceri, Sergio Cortelazzo
Publikováno v:
HemaSphere. 3:65-66
Autor:
Annamaria Scattolin, E. Oldani, O Spinelli, S. Imbergamo, T Intermesoli, Elena Maino, R. Bassan, A. Rambaldi
Publikováno v:
Drugs and Cell Therapies in Hematology. 2
SUMMARY Monoclonal antibody therapy for adult acute lymphoblastic leukemia is an emerging therapeutic option which offers substantial opportunities to improve treatment results. The evidence in favor of this approach is presented as a challenge to de
Autor:
Daniele Mattei, Renato Bassan, Elena Oldani, Annamaria Scattolin, Erika Borlenghi, Claudio Romani, E Di Bona, Fabio Ciceri, Enrico Pogliani, Agostino Cortelezzi, Vincenzo Cassibba, Ernesta Audisio, Barbara Peruta, Manuela Tosi, Giacomo Gianfaldoni, Alessandro Rambaldi, Tamara Intermesoli, Orietta Spinelli
Publikováno v:
Blood Cancer Journal
Different molecular levels of post-induction minimal residual disease may predict hematopoietic stem cell transplantation outcome in adult Philadelphia-negative acute lymphoblastic leukemia